Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Heart

• Publication date

  2008-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/hrt.2007.140905PMID 18381374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigating patients' and general practitioners' views of computerised decision support software for the assessment and management of cardiovascular risk.

  2007cited by this paper
• Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

  2007cited by this paper
• Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1).

  2006cited by this paper
• Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.

  2006cited by this paper
• The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.

  2006cited by this paper
• Treatment With Drugs to Lower Blood Pressure and Blood Cholesterol Based on an Individual's Absolute Cardiovascular Risk

  2006cited by this paper
• Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)

  2005cited by this paper
• Scaled rectangle diagrams can be used to visualize clinical and epidemiological data.

  2005cited by this paper
• Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk.

  2005cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

  2003cited by this paper
• Secondary prevention in coronary artery disease patients in South Auckland: moving targets and the current treatment gap.

  2003cited by this paper
• Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

  2003cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

  2003cited by this paper
• Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries

  2001cited by this paper
• Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.

  2001cited by this paper
• Primary and subsequent coronary risk appraisal: new results from the Framingham study.

  2000cited by this paper
• European Action on Secondary Prevention by Intervention to Reduce Events

  1998cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Cardiovascular disease risk profiles.

  1991cited by this paper

• Medication adherence to lipid-lowering agents after percutaneous coronary intervention: nationwide real-world data in the Netherlands.

  2026cites this paper
• Saudi Secondary Prevention Survey Study in Patients with Prior Acute Myocardial Infarction (4S Registry): Study Design and Pilot Phase Results.

  2026cites this paper
• Cardiac Rehabilitation Program-Related Factors Associated With Morbidity Among Patients in Low-Resource Settings: ANALYSIS FROM THE INTERNATIONAL CARDIAC REHABILITATION REGISTRY.

  2026cites this paper
• Think-aloud test of online education for patients with cardiac diseases: do they meet the needs of women?

  2025cites this paper
• Dose‒response associations of self-reported and device-measured physical activity with major adverse cardiovascular events in people with prevalent diseases.

  2025cites this paper
• Engaging women with lived experience in tailoring educational resources for cardiovascular rehabilitation.

  2025cites this paper
• Spanish Translation, Adaptation, and Validation of Strategies to Mitigate Cardiac Rehabilitation Barriers

  2025cites this paper
• Technology‐bAsed cardiac rehabilitation therapy (TaCT) for women: Intervention implementability, usability, engagement and acceptability in a middle‐income setting

  2025cites this paper
• Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan

  2025cites this paper
• Gender differences in the association between Life's essential 8 and cardiovascular disease: a U.S.-based cross-sectional analysis

  2025influential citation
• Technology-based comprehensive cardiac rehabilitation therapy for women in a middle-income setting: a randomized controlled trial.

  2025cites this paper
• Psychometric validation of the short version of the Information Needs in Cardiac Rehabilitation scale through a first global assessment.

  2024cites this paper
• Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease

  2024cites this paper
• Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil.

  2024cites this paper
• Prévention primaire de la maladie athéromateuse – un objectif prioritaire : dépister le haut risque cardiovasculaire

  2024cites this paper
• World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update

  2024cites this paper
• Rationale, Design and Baseline Characteristics of a Randomized Controlled Trial of a Cardiovascular Quality Improvement Strategy in India: The C-QIP Trial.

  2024cites this paper
• WHF Roadmap on Secondary Prevention of CVD

  2024cites this paper
• Characterizing health literacy in cardiac rehabilitation patients: a decade of multinational data (2014–2024)

  2024cites this paper
• Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study.

  2024cites this paper
• Healthcare service utilisation among adults with coronary artery disease in rural Aluva, South India: a community-based cross-sectional study

  2024cites this paper
• Severe Periodontitis is Associated With Recurrent Cardiovascular Events—A 10‐Year Longitudinal Cohort Study

  2024cites this paper
• Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy

  2024cites this paper
• Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: an implementation study

  2023cites this paper
• Wildfire, evacuation, and cardiovascular events: A spatial exposure approach

  2023cites this paper
• Social Determinants of Health Data Improve the Prediction of Cardiac Outcomes in Females with Breast Cancer

  2023cites this paper
• Association of Healthy Sleep Pattern with Risk of Recurrent Cardiovascular Events among Patients with Coronary Heart Disease.

  2023cites this paper
• Development and validation of cardiovascular risk prediction equations in 76,000 people with known cardiovascular disease.

  2023cites this paper
• Threshold values of brachial cuff-measured arterial stiffness indices determined by comparisons with the brachial–ankle pulse wave velocity: a cross-sectional study in the Chinese population

  2023cites this paper
• Evidence-informed development of women-focused cardiac rehabilitation education.

  2023cites this paper
• Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer.

  2023cites this paper
• Non-acute chest pain in primary care; referral rates, communication and guideline adherence: a cohort study using routinely collected health data

  2022cites this paper
• Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology

  2022cites this paper
• Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial

  2021cites this paper
• Adherence to antihypertensive medications for secondary prevention of cardiovascular disease events: a dose-response meta-analysis.

  2021cites this paper
• Novel Pickering High Internal Phase Emulsion Stabilized by Food Waste-Hen Egg Chalaza

  2021cites this paper
• Assessment of Dietary Habits Using the Diet Quality Index—International in Cerebrovascular and Cardiovascular Disease Patients

  2021cites this paper
• Efficacy and Safety of Text Messages Targeting Adherence to Cardiovascular Medications in Secondary Prevention: TXT2HEART Colombia Randomized Controlled Trial (Preprint)

  2020cites this paper
• Cardiovascular Risk in Mild to Moderately Decreased Glomerular Filtration Rate, Diabetes and Coronary Heart Disease in a Southern European Region.

  2020cites this paper
• Riesgo cardiovascular en la disminución leve-moderada de la tasa de filtrado glomerular, diabetes y enfermedad coronaria en un área del sur de Europa

  2020cites this paper
• Walking the tightrope: cardiovascular risk prediction in patients after acute coronary syndrome

  2020cites this paper
• Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE Risk Model.

  2020cites this paper
• Efficacy and Safety of Text Messages Targeting Adherence to Cardiovascular Medications in Secondary Prevention: TXT2HEART Colombia Randomized Controlled Trial

  2020cites this paper
• Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China

  2020cites this paper
• A Score to differentiate Takotsubo syndrome from non-ST-elevation myocardial nfarction in women at the bedside

  2020cites this paper
• Cholesterol-Lowering Agents: Statins—For Everyone?

  2019cites this paper
• Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome

  2019cites this paper
• Cardiovascular Disease among Syrian refugees: a descriptive study of patients in two Médecins Sans Frontières clinics in northern Lebanon

  2019cites this paper
• Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS)

  2019cites this paper
• How simple mistakes and short-term bias elevate cardiovascular risk.

  2018cites this paper
• TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol

  2018cites this paper
• Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study.

  2018cites this paper
• Polypills for the secondary prevention of cardiovascular disease: effective in improving adherence but are they safe?

  2018cites this paper
• Benefits and Costs of the Noncommunicable Disease Targets for the Post-2015 Development Agenda

  2018cites this paper
• Statine en prévention primaire : est-ce requis pour tous ?

  2017cites this paper
• The Contribution of Individual Exercise Training Components to Clinical Outcomes in Randomised Controlled Trials of Cardiac Rehabilitation: A Systematic Review and Meta-regression

  2017cites this paper
• Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease.

  2017cites this paper
• Developing and validating a cardiovascular risk score for patients in the community with prior cardiovascular disease

  2017cites this paper
• Risk factor control in secondary prevention of cardiovascular disease: results from the multi-ethnic HELIUS study

  2017cites this paper
• Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care

  2017cites this paper
• The electronic tracking of referral and attendance at cardiac rehabilitation in Counties Manukau Health: a potential model for New Zealand.

  2016cites this paper
• Evaluating a Web-Based Self-Management Intervention in Heart Failure Patients: A Pilot Study

  2016cites this paper
• Inaccurate risk perceptions contribute to treatment gaps in secondary prevention of cardiovascular disease

  2016cites this paper
• How health technology helps promote cardiovascular health outcomes

  2016cites this paper
• Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

  2016cites this paper
• Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial

  2016cites this paper
• ‘Surfing’ the cardiovascular epidemic SURF (SUrvey of Risk Factors), a welcome initiative to improve monitoring of patients with coronary heart disease

  2016cites this paper
• Effectiveness and safety of a cardiovascular polypill containing aspirin

  2015cites this paper
• Lignes directrices simplifiées sur les lipides Prévention et prise en charge des maladies cardiovasculaires en soins primaires

  2015cites this paper
• Benefits and Costs of the Non- Communicable Disease Targets for the Post-2015 Development Agenda

  2015cites this paper
• Mobile phone text messaging to improve adherence to cardiovascular disease secondary prevention interventions

  2015cites this paper
• Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease.

  2015cites this paper
• Cohort Profile Cohort Profile : The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care ( PREDICT-CVD 19 )

  2015cites this paper
• Simplified lipid guidelines: Prevention and management of cardiovascular disease in primary care.

  2015cites this paper
• Mild hypertension in people at low risk

  2014cites this paper
• Risks in estimating risk.

  2014cites this paper
• Effective ways to prevent recurrence of acute coronary syndrome

  2014cites this paper
• Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians – A population with the highest risk of premature coronary artery disease & diabetes

  2013cites this paper
• NT-proBNP Best Predictor of Cardiovascular Events and Cardiovascular Mortality in Secondary Prevention in Very Old Age: The Leiden 85-Plus Study

  2013cites this paper
• Vascular risk calculators: essential but flawed clinical tools?

  2013cites this paper
• Improving outcomes after acute coronary syndrome with rehabilitation and secondary prevention.

  2013cites this paper
• Providing cardiovascular risk management information to acute coronary syndrome patients: a randomized trial.

  2013cites this paper
• Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration.

  2013cites this paper
• The Lower, the Better?

  2013cites this paper
• The Evolution or Revolution of Statin Therapy in Primary Prevention: Where Do We Go From Here?

  2013cites this paper
• Agreement Among Cardiovascular Disease Risk Calculators

  2013cites this paper
• Prognostic value of cardiovascular disease status: the Leiden 85-plus study

  2012cites this paper
• Cardiovascular risk prediction in Central and Eastern Europe and former Soviet Union

  2012cites this paper
• Why measure resting heart rate?

  2012cites this paper
• The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

  2012cites this paper
• Non-adherence to medication and cardiovascular risk.

  2011cites this paper
• Validez relativa de la estimación del riesgo cardiovascular a 10 años en una cohorte poblacional del estudio REGICOR

  2011cites this paper
• Discordant age and sex-specific trends in the incidence of a first coronary heart disease event in Western Australia from 1996 to 2007

  2011cites this paper
• Cardiac rehabilitation – moving forward with new models of care

  2011cites this paper
• Nurse-Led Cardiovascular Disease Risk Management Intervention for Patients with Gout

  2011cites this paper
• Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.

  2011influential citation
• [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study].

  2011cites this paper
• Cardiovascular and Economic Outcomes After Initiation of Atorvastatin versus Simvastatin in an Employed Population Stratified by Cardiovascular Risk

  2011cites this paper
• Relative Validity of the 10-Year Cardiovascular Risk Estimate in a Population Cohort of the REGICOR Study

  2011cites this paper
• Nurse-led clinics as an effective service for cardiac patients: results from a systematic review.

  2011cites this paper